ABSCI CORP Share-based Payment Arrangement, Expense
ABSCI CORP (ABSI) reported Share-based Payment Arrangement, Expense of $5.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-11
- ABSCI CORP share-based payment arrangement, expense for the quarter ending 2026-06-30 was $5.25M, a 10.37% increase year-over-year.
- ABSCI CORP share-based payment arrangement, expense for the quarter ending 2026-03-31 was $4.38M, a 11.39% decline year-over-year.
- ABSCI CORP share-based payment arrangement, expense for the quarter ending 2025-12-31 was $4.26M, a 15.96% decline year-over-year.
- ABSCI CORP share-based payment arrangement, expense for the quarter ending 2025-09-30 was $4.40M, a 20.19% decline year-over-year.
- ABSCI CORP share-based payment arrangement, expense for fiscal 2025 was $18.35M, a 5.74% decline from fiscal 2024.
- ABSCI CORP share-based payment arrangement, expense for fiscal 2024 was $19.47M, a 69.98% increase from fiscal 2023.
- ABSCI CORP share-based payment arrangement, expense for fiscal 2023 was $11.45M, a 9.51% decline from fiscal 2022.
- ABSCI CORP share-based payment arrangement, expense for fiscal 2022 was $12.66M, a 19.33% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.25M 10-Q · filed 2026-08-11 | $9.63M 10-Q · filed 2026-08-11 | $13.88M derived: sum of 3 quarters · filed 2026-08-11 | $18.28M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $4.38M 10-Q · filed 2026-05-07 | $8.64M derived: sum of 2 quarters · filed 2026-05-07 | $13.04M derived: sum of 3 quarters · filed 2026-05-07 | $17.79M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $8.65M derived: sum of 2 quarters · filed 2026-03-24 | $13.41M derived: sum of 3 quarters · filed 2026-08-11 | $18.35M 10-K · filed 2026-03-24 |
| 2025-09-30 | $4.40M 10-Q · filed 2025-11-12 | $9.15M derived: sum of 2 quarters · filed 2026-08-11 | $14.09M 10-Q · filed 2025-11-12 | $19.16M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $4.75M 10-Q · filed 2026-08-11 | $9.70M 10-Q · filed 2026-08-11 | $14.76M derived: sum of 3 quarters · filed 2026-08-11 | $20.27M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $4.94M 10-Q · filed 2026-05-07 | $10.01M derived: sum of 2 quarters · filed 2026-05-07 | $15.52M derived: sum of 3 quarters · filed 2026-05-07 | $20.82M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $10.58M derived: sum of 2 quarters · filed 2026-03-24 | $15.87M derived: sum of 3 quarters · filed 2026-03-24 | $19.47M 10-K · filed 2026-03-24 |
| 2024-09-30 | $5.51M 10-Q · filed 2025-11-12 | $10.80M derived: sum of 2 quarters · filed 2025-11-12 | $14.40M 10-Q · filed 2025-11-12 | $17.58M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $5.30M 10-Q · filed 2025-08-12 | $8.89M 10-Q · filed 2025-08-12 | $12.07M derived: sum of 3 quarters · filed 2025-08-12 | $14.63M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $3.60M 10-Q · filed 2025-05-13 | $6.78M derived: sum of 2 quarters · filed 2025-05-13 | $9.33M derived: sum of 3 quarters · filed 2025-05-13 | $12.38M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $5.73M derived: sum of 2 quarters · filed 2025-03-18 | $8.79M derived: sum of 3 quarters · filed 2025-03-18 | $11.45M 10-K · filed 2025-03-18 |
| 2023-09-30 | $2.55M 10-Q · filed 2024-11-12 | $5.61M derived: sum of 2 quarters · filed 2024-11-12 | $8.27M 10-Q · filed 2024-11-12 | $9.31M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $3.05M 10-Q · filed 2024-08-14 | $5.72M 10-Q · filed 2024-08-14 | $6.76M derived: sum of 3 quarters · filed 2024-08-14 | $10.35M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $2.67M 10-Q · filed 2024-05-14 | $3.71M derived: sum of 2 quarters · filed 2024-05-14 | $7.30M derived: sum of 3 quarters · filed 2024-05-14 | $11.54M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $4.63M derived: sum of 2 quarters · filed 2024-03-21 | $8.88M derived: sum of 3 quarters · filed 2024-03-21 | $12.66M 10-K · filed 2024-03-21 |
| 2022-09-30 | $3.59M 10-Q · filed 2023-11-14 | $7.84M derived: sum of 2 quarters · filed 2023-11-14 | $11.62M 10-Q · filed 2023-11-14 | $14.85M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $4.25M 10-Q · filed 2023-08-14 | $8.03M 10-Q · filed 2023-08-14 | $11.26M derived: sum of 3 quarters · filed 2023-08-14 | $15.04M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $3.78M 10-Q · filed 2023-05-15 | $7.01M derived: sum of 2 quarters · filed 2023-05-15 | $10.79M derived: sum of 3 quarters · filed 2023-05-15 | $12.24M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $7.01M derived: sum of 2 quarters · filed 2023-03-30 | $8.46M derived: sum of 3 quarters · filed 2023-03-30 | $10.61M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.78M 10-Q · filed 2022-11-09 | $5.22M derived: sum of 2 quarters · filed 2022-11-09 | $7.38M 10-Q · filed 2022-11-09 | $7.64M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.44M 10-Q · filed 2022-08-11 | $3.59M 10-Q · filed 2022-08-11 | $3.86M derived: sum of 3 quarters · filed 2022-08-11 | $3.95M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.15M 10-Q · filed 2022-05-11 | $2.42M derived: sum of 2 quarters · filed 2022-05-11 | $2.51M derived: sum of 3 quarters · filed 2022-05-11 | $2.56M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $354.00K derived: sum of 2 quarters · filed 2022-03-22 | $412.00K derived: sum of 3 quarters · filed 2022-03-22 | $420.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $86.00K 10-Q · filed 2021-11-09 | $144.00K derived: sum of 2 quarters · filed 2021-11-09 | $152.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $58.00K 10-Q · filed 2021-09-07 | $66.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |